来自MSN26 天
ASCO GI: RenovoRX’s TAMP system reduces side effects in pancreatic cancer
California medical device company RenovoRx’s Trans-Arterial Micro-Perfusion (TAMP ... III trial in patients living with locally advanced pancreatic cancer (LAPC). Presented as part of the ...
Kaleido Scope3 个月
UAB experts investigate the effectiveness of P4 phantom on neoadjuvant chemotherapy ...
Borderline-resectable pancreatic cancer (BRPC) accounts for nearly 20% of all pancreatic cancer ... In a pilot study, experts used the Point-of-Care Portable Perfusion Phantom™ (P4 Phantom ™), ...